%D8%B9%D8%B3%D8%B1_%D8%B4%D8%AD%D9%85%D9%8A%D8%A7%D8%AA_%D8%A7%D9%84%D8%AF%D9%85Dislip%C3%A8miaFettstoffwechselst%C3%B6rungDyslipidemiaDislipidemia%D8%AF%DB%8C%D8%B3%E2%80%8C%D9%84%DB%8C%D9%BE%DB%8C%D8%AF%D9%85%DB%8CDyslipid%C3%A9mieHiperlipidemiasDislipidemijaDislipidemiaDislipidemia%D0%94%D0%B8%D1%81%D0%BB%D0%B8%D0%BF%D0%B8%D0%B4%D0%B5%D0%BC%D0%B8%D1%98%D0%B0DislipidemiaDislipidemiaDislipidemieDyslipid%C3%A9miaDislipidemijaR%E1%BB%91i_lo%E1%BA%A1n_m%E1%BB%A1_m%C3%A1uQ1476525
about
sameAs
hyperlipidemialipoprotein glomerulopathysteroid inherited metabolic disorderinborn error of lipid metabolismadult Refsum diseasefamilial hyperlipidemiacarnitine palmitoyltransferase II deficiencylipoid proteinosiscarnitine palmitoyltransferase I deficiencyrare dyslipidemiahypolipoproteinemiamultiple congenital anomalies-hypotonia-seizures syndromedyslipidemiasshort-chain acyl-coenzyme A dehydrogenase deficiencymedium chain acyl-CoA dehydrogenase deficiencyvery long chain acyl-CoA dehydrogenase deficiencyBarth syndromechylomicron retention diseaseSmith-Lemli-Opitz syndrome
P279
Pitavastatin in cardiometabolic disease: therapeutic profileFructose, insulin resistance, and metabolic dyslipidemiaEzetimibe therapy: mechanism of action and clinical updateAntiretroviral therapy and dyslipidaemia: unlocking the code.A general introduction to the biochemistry of mitochondrial fatty acid β-oxidationCommon medications used by patients with type 2 diabetes mellitus: what are their effects on the lipid profile?Nutraceuticals and Bioactive Components from Fish for Dyslipidemia and Cardiovascular Risk ReductionThe Intestinal Microbiota in Metabolic DiseaseNiacin Alternatives for Dyslipidemia: Fool's Gold or Gold Mine? Part II: Novel Niacin MimeticsNiacin Alternatives for Dyslipidemia: Fool's Gold or Gold Mine? Part I: Alternative Niacin Regimens.Effects of Sitagliptin on Lipid Profiles in Patients With Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Clinical TrialsEffects of Vegetarian Diets on Blood Lipids: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsEffect of Fructose on Established Lipid Targets: A Systematic Review and Meta-Analysis of Controlled Feeding TrialsLDL electronegativity index: a potential novel index for predicting cardiovascular diseaseNew developments in atherosclerosis: clinical potential of PCSK9 inhibitionBent spine syndrome as an initial manifestation of late-onset multiple acyl-CoA dehydrogenase deficiency: a case report and literature reviewLipid-lowering therapy: who can benefit?Lipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approachesAssociation of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysisChallenges in the pharmacologic management of obesity and secondary dyslipidemia in children and adolescentsTreatment of dyslipidemia with statins and physical exercises: recent findings of skeletal muscle responsesStatins in cardiometabolic disease: what makes pitavastatin different?Cholesterol: the good, the bad, and the ugly - therapeutic targets for the treatment of dyslipidemiaLifestyle interventions for hypertension and dyslipidemia among women of reproductive ageNonalcoholic fatty liver disease: new treatmentsThe roles of genetic polymorphisms and human immunodeficiency virus infection in lipid metabolismOvercoming Challenges With Statin TherapyAssociation between subjective social status and cardiovascular disease and cardiovascular risk factors: a systematic review and meta-analysisWhy Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?Lipid metabolism disorders and bone dysfunction--interrelated and mutually regulated (review)Mitochondrial dysfunction in fatty acid oxidation disorders: insights from human and animal studiesUnique features of high-density lipoproteins in the Japanese: in population and in genetic factorsAtherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statinsOptimal lipid modification: the rationale for combination therapyFenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a reviewFenofibric acid: a new fibrate approved for use in combination with statin for the treatment of mixed dyslipidemiaRelative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illnesses: systematic review and metaanalysis.Lipid, blood pressure and kidney update 2013.Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.Effect of statins on cardiovascular events in patients with mild to moderate chronic kidney disease: a systematic review and meta-analysis of randomized clinical trials.
P921
description
An inherited acute metabolic d ...... ion and degradation of lipids.
@en
Krankheit
@de
condizione clinica nella quale sono presenti nel sangue elevate concentrazioni di lipidi
@it
maladie provoquant un niveau anormal des graisses du sang
@fr
αύξηση λιπιδίων στο αίμα (Chol ...... ρες ή HDL < 46 mg/dl γυναίκες)
@el
مرض يصيب الإنسان
@ar
name
Dislipidemia
@id
Dislipidemia
@ms
Dislipidemie
@ro
Dislipidemija
@hr
Dislipidemija
@sl
Dyslipidemia
@nl
Dyslipidémia
@sk
Fettstoffwechselstörung
@de
Hiperlipidemias
@gl
Rối loạn mỡ máu
@vi
type
label
Dislipidemia
@id
Dislipidemia
@ms
Dislipidemie
@ro
Dislipidemija
@hr
Dislipidemija
@sl
Dyslipidemia
@nl
Dyslipidémia
@sk
Fettstoffwechselstörung
@de
Hiperlipidemias
@gl
Rối loạn mỡ máu
@vi
altLabel
Dislipemia
@gl
Dislipidaemia
@id
Dyslipidämie
@de
dislipemia
@es
dislipidemie
@it
dislipidèmia
@ca
dislipidémia
@pt
dyslipidemi
@nn
dyslipidemia
@en
dyslipidemie
@fr
prefLabel
Dislipidemia
@id
Dislipidemia
@ms
Dislipidemie
@ro
Dislipidemija
@hr
Dislipidemija
@sl
Dyslipidemia
@nl
Dyslipidémia
@sk
Fettstoffwechselstörung
@de
Hiperlipidemias
@gl
Rối loạn mỡ máu
@vi
P2176
P2293
P2888
P2892
P2581
P486
P6366
P646
P672
P1550
P1995
P2581
P2892
P31
P3471
P3827
dyslipidemias
P3841
HP:0003119
P486
P6366
2778096610
2909255014